Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Agex Therapeutics Inc
(NY:
AGE
)
N/A
UNCHANGED
Last Price
Updated: 8:00 PM EDT, Mar 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Agex Therapeutics Inc
AGEX THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of AgeX Therapeutics, Inc. - AGE
February 27, 2024
From
Kahn Swick & Foti, LLC
Via
Business Wire
AgeX Therapeutics Reports Third Quarter 2023 Financial Results
November 14, 2023
From
AgeX Therapeutics, Inc.
Via
Business Wire
AGEX THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of AgeX Therapeutics, Inc. - AGE
September 05, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
AGE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of AgeX Therapeutics, Inc. Is Fair to Shareholders
August 30, 2023
From
Halper Sadeh LLC
Via
Business Wire
Serina Therapeutics and AgeX Therapeutics Enter into Merger Agreement
August 30, 2023
From
AgeX Therapeutics, Inc.
Via
Business Wire
AgeX Therapeutics Reports Second Quarter 2023 Financial Results
August 14, 2023
From
AgeX Therapeutics, Inc.
Via
Business Wire
AgeX Therapeutics Closes $36,000,000 Debt Exchange for Preferred Stock
July 24, 2023
From
AgeX Therapeutics, Inc.
Via
Business Wire
AgeX Therapeutics Announces $36,000,000 Debt Exchange for Preferred Stock
July 21, 2023
From
AgeX Therapeutics, Inc.
Via
Business Wire
AgeX Therapeutics Announces Appeal of NYSE American Determination
May 23, 2023
From
AgeX Therapeutics, Inc.
Via
Business Wire
AgeX Therapeutics Reports First Quarter 2023 Financial Results
May 12, 2023
From
AgeX Therapeutics, Inc.
Via
Business Wire
AgeX Therapeutics Receives Stock Exchange Deficiency Letter
April 26, 2023
From
AgeX Therapeutics , Inc.
Via
Business Wire
AgeX Therapeutics Reports Fourth Quarter and Annual 2022 Financial Results
March 31, 2023
From
AgeX Therapeutics, Inc.
Via
Business Wire
AgeX Therapeutics Receives Extension of Time to Attain Compliance With Stock Exchange Continued Listing Requirements
November 25, 2022
From
AgeX Therapeutics, Inc.
Via
Business Wire
AgeX Therapeutics Reports Third Quarter 2022 Financial Results
November 10, 2022
From
AgeX Therapeutics, Inc.
Via
Business Wire
AgeX Therapeutics Reports Second Quarter 2022 Financial Results
August 12, 2022
From
AgeX Therapeutics, Inc.
Via
Business Wire
Dr. Joanne Hackett Appointed Chairperson of AgeX Board of Directors
May 18, 2022
From
AgeX Therapeutics, Inc.
Via
Business Wire
AgeX Therapeutics Reports First Quarter 2022 Financial Results
May 13, 2022
From
AgeX Therapeutics, Inc.
Via
Business Wire
AgeX Therapeutics Reports Fourth Quarter and Annual 2021 Financial Results
March 29, 2022
From
AgeX Therapeutics, Inc.
Via
Business Wire
AgeX Therapeutics to Collaborate With University of California, Irvine, on Research Program for Exosome-Based Therapies for Certain Brain Disorders
December 14, 2021
From
AgeX Therapeutics, Inc.
Via
Business Wire
Braeden Lichti: The Business of Anti-Aging and Rejuvenation Biotechnology
December 31, 2021
VANCOUVER, British Columbia - Dec. 31, 2021 - PRLog -- 2020-07-30: Scientists now have a better understanding into the aging process, giving us a better explanation of the cellular changes that lead...
Via
PRLog
Topics
Artificial Intelligence
Intellectual Property
Exposures
Artificial Intelligence
Intellectual Property
AgeX Therapeutics’ Licensee ImStem Biotechnology Announces First U.S. Multiple Sclerosis Patient Dosed with IMS001
November 30, 2021
From
AgeX Therapeutics, Inc.
Via
Business Wire
AgeX Therapeutics Receives Stock Exchange Deficiency Letter
November 23, 2021
From
AgeX Therapeutics , Inc.
Via
Business Wire
AgeX Therapeutics Reports Third Quarter 2021 Financial Results
November 12, 2021
From
AgeX Therapeutics, Inc.
Via
Business Wire
AgeX Therapeutics Reports Second Quarter 2021 Financial Results
August 13, 2021
From
AgeX Therapeutics, Inc.
Via
Business Wire
AgeX Therapeutics and LyGenesis Terminate Merger Negotiations
July 23, 2021
From
AgeX Therapeutics, Inc.
Via
Business Wire
AgeX Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
May 17, 2021
From
AgeX Therapeutics
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.